PBT2 has already been tested (Tanzis Letter to AGM) see PDF...

PBT2 has already been tested (Tanzis Letter to AGM) see PDF below

https://research.iress.com.au/ids/o...765800005D7940720CB6E440C4390100AD430000&ppv=

"So far, the preliminary findings show that PBT2 has the following effects in Alzheimer’s-in-a-Dish: 1. A trend in the direction of attenuation of the aggregation and fibrillization of the Abeta peptide into betaamyloid, 2. significantly reduced tangle formation, and 3. significantly increased cell viability. Once these results are confirmed, PBT2 would become the only compound tested in Alzheimer’s-in-a-Dish to achieve all three of these effects on AD pathology. In closing, based on recent findings, I firmly believe, that beta-amyloid remains the best target for preventing and treating AD, but this must be achieved in the earliest stages of the disease process. Based on the combined data, I continue to believe that PBT2 carries great potential for curbing plaque and tangle formation, while also enhancing neuronal cell viability as an AD therapeutic."

Rudi Tanzi Nov 12th 2015